References

ARVO Annual Meeting 2022

Johnson, G., Pham, J., Kodati, B., Krishnamoorthy, R., Nagaraj, R., Stankowska, D. (2022). Mechanisms of Peptain-mediated neuroprotection in Retinal Ganglion Cells. Poster Presentation. ARVO Annual Meeting May 1-4, 2022.

1.  Allison, K., Patel, D., & Alabi, O. (2020). Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus, 12(11), e11686. https://doi.org/10.7759/cureus.11686

2. Nahomi, R.B., et al., Chaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts. J Biol Chem, 2013. 288(18): p. 13022-35.

3. Stankowska, D.L., Nam, M. H., Nahomi, R. B., Chaphalkar, R. M., Nandi, S. K., Fudala, R., Krishnamoorthy, R. R., & Nagaraj, R. H., Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: Implications for neuroprotection in glaucoma. . Cell Death Discovery, 2019. 5.

ISER Meeting 2022

Kodati, B., Krishnamoorthy, V.R., Nahomi, R.B., Johnson, G.A., Nam, M., Nagaraj, R.H., Krishnamoorthy, R., Stankowska, D. (2022). Novel Peptain for Neuroprotection in Glaucoma. Poster Presentation. ISER Meeting, May 25-27, 2022.

1.  Munemasa, Y., & Kitaoka, Y. (2013). Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection. Frontiers in cellular neuroscience, 6, 60. https://doi.org/10.3389/fncel.2012.00060

2. Stankowska, D.L., Nam, M. H., Nahomi, R. B., Chaphalkar, R. M., Nandi, S. K., Fudala, R., Krishnamoorthy, R. R., & Nagaraj, R. H., Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: Implications for neuroprotection in glaucoma. . Cell Death Discovery, 2019. 5.

3. Johnson, G., Pham, J., Kodati, B., Krishnamoorthy, R., Nagaraj, R., Stankowska, D. (2022). Mechanisms of Peptain-mediated neuroprotection in Retinal Ganglion Cells. Poster Presentation. ARVO Annual Meeting May 1-4, 2022.

ARVO Annual Meeting 2023

Johnson, G., Pham, J., Nagaraj, R., Stankowska, D. (2023). P1-CPP Promotes FOXO1 and Creb Signaling and Reduces Apoptosis in Neurotrophic Factor-Deprived Primary Retinal Ganglion Cells. Poster Presentation. ARVO Annual Meeting April 23-27, 2023.

1. Nagaraj, R.H., et al., Therapeutic potential of α-crystallin. Biochim Biophys Acta, 2016. 1860(1 Pt B): p. 252-7.

2. Nahomi, R.B., S.K. Nandi, and R.H. Nagaraj, A monoclonal antibody targeted to the functional peptide of αB-crystallin inhibits the chaperone and anti-apoptotic activities. J Immunol Methods, 2019. 467: p. 37-47.

3. Stankowska, D.L., Nam, M. H., Nahomi, R. B., Chaphalkar, R. M., Nandi, S. K., Fudala, R., Krishnamoorthy, R. R., & Nagaraj, R. H., Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: Implications for neuroprotection in glaucoma. . Cell Death Discovery, 2019. 5.

4. Walton, M.R. and I. Dragunow, Is CREB a key to neuronal survival? Trends Neurosci, 2000. 23(2): p. 48-53.